Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders

Molecules. 2018 Jul 24;23(8):1836. doi: 10.3390/molecules23081836.

Abstract

CB2 cannabinoid receptor (CB2R) gene is associated with depression. We investigated the gene-environment interaction between CB2R function and diverse stressors. First, anxiety-like behavior during chronic-mild-stress (CMS) was evaluated in C57BL/6JJmsSlc mice following treatment with CB2R agonist JWH015 or inverse-agonist AM630. Second, locomotor activity and anxiety-like behavior were measured following exposure to an immune poly I:C stressor. Gene expressions of HPA axis related molecules, Fkbp5, Nr3c1 and Crf and pro-inflammatory cytokine Il-1b, as well as Bdnf as a key neurotrophin that supports neuron health, function, and synaptic plasticity, were determined in hippocampus of Cnr2 knockout mice, as indicators of stressful environment. CMS-induced anxiety-like behavior was enhanced by AM630 and reduced by JWH015 and fluvoxamine. Poly I:C reduced locomotor activity and increased anxiety-like behavior, and these effects were pronounced in the heterozygote than in the wild type mice. Fkbp5 and Nr3c1 expression were lower in the Cnr2 heterozygotes than in the wild type mice with Poly I:C treatment. These findings indicate that interaction between CB2R gene and stressors increases the risk of depression-like behaviors that may be linked with neuro-immune crosstalk. Further studies in human subjects are necessary to determine the role of CB2R and environmental interaction in the development of depression.

Keywords: Cnr2; HPA axis; anxiety; cannabinoid CB2 receptor; chronic mild stress; depression; endocannabinoid; neuro-immune signaling.

MeSH terms

  • Animals
  • Anxiety / chemically induced
  • Anxiety / genetics*
  • Anxiety / immunology
  • Anxiety / physiopathology
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / immunology
  • Cannabinoid Receptor Agonists / pharmacology
  • Corticotropin-Releasing Hormone / genetics
  • Corticotropin-Releasing Hormone / immunology
  • Depression / chemically induced
  • Depression / genetics*
  • Depression / immunology
  • Depression / physiopathology
  • Disease Models, Animal
  • Gene Expression Regulation
  • Gene-Environment Interaction*
  • Hippocampus / drug effects
  • Hippocampus / immunology
  • Hippocampus / physiopathology
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / immunology*
  • Hypothalamo-Hypophyseal System / physiopathology
  • Immunologic Factors / administration & dosage
  • Indoles / pharmacology
  • Interleukin-1beta / genetics
  • Interleukin-1beta / immunology
  • Locomotion / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Pituitary-Adrenal System / drug effects
  • Pituitary-Adrenal System / immunology*
  • Pituitary-Adrenal System / physiopathology
  • Poly I-C / administration & dosage
  • Receptor, Cannabinoid, CB2 / deficiency
  • Receptor, Cannabinoid, CB2 / genetics*
  • Receptor, Cannabinoid, CB2 / immunology
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / immunology
  • Signal Transduction
  • Tacrolimus Binding Proteins / genetics
  • Tacrolimus Binding Proteins / immunology

Substances

  • Brain-Derived Neurotrophic Factor
  • Cannabinoid Receptor Agonists
  • Cnr2 protein, mouse
  • IL1B protein, mouse
  • Immunologic Factors
  • Indoles
  • Interleukin-1beta
  • NR3C1 protein, mouse
  • Receptor, Cannabinoid, CB2
  • Receptors, Glucocorticoid
  • Corticotropin-Releasing Hormone
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 5
  • Poly I-C
  • iodopravadoline
  • JHW 015